COMPARISON OF EFFICACY OF GLYCOLIC ACID 60% PEEL VERSUS Q-SWITCHED Nd: YAG LASER IN THE TREATMENT OF MELASMA AT TERTIARY CARE HOSPITAL OF BAHAWALPUR

A RAFIQUE; A HABIB; S MAJEED; M HAFEEZ; F JABEEN; TA MUNIR

doi:10.54112/pjicm.v5i02.100

Authors

A RAFIQUE Department of Dermatology, CMH, Bahawalpur, Pakistan
A HABIB Department of Dermatology, CMH, Bahawalpur, Pakistan
S MAJEED Department OF AHS, BMDC Bahawalpur, Pakistan
M HAFEEZ Department of Dermatology, CMH, Bahawalpur, Pakistan
F JABEEN Department of Dermatology, CMH, Bahawalpur, Pakistan
TA MUNIR Department of Physiology, BMDC Bahawalpur, Pakistan

DOI:

https://doi.org/10.54112/pjicm.v5i02.100

Keywords:

Glycolic-acid 60%, Laser Q-switched Nd: YAG, Melasma

Abstract

Background: Melasma is a common acquired pigmentary disorder, especially among individuals with darker skin types. Various therapeutic modalities, including chemical peels and lasers, are used to manage melasma; however, their comparative effectiveness remains a subject of ongoing clinical investigation. Objective: To compare the therapeutic efficacy and safety profile of low-fluence Q-switched Nd: YAG laser with topical 60% glycolic acid peel in the treatment of melasma. Study Design: Quasi-experimental, non-randomized controlled study. Setting: Department of Dermatology, Combined Military Hospital (CMH), Bahawalpur, Pakistan. Duration of Study: From 15 April to 14 September 2024. Methods: Eighty patients clinically diagnosed with melasma were enrolled and divided into two groups: Group A (n=40) received 60% glycolic acid peels and Group B (n=40) received low-fluence Q-switched Nd: YAG laser therapy. Each patient received treatment for a period of three months. Treatment efficacy was assessed using the Melasma Area and Severity Index (MASI) at baseline and 8 weeks. Statistical analysis included a median score comparison and a chi-square test for categorical data, with p < 0.05 considered statistically significant. Results: The peak incidence of melasma was observed in the 29–32-year age group, with a female-to-male ratio of 4:1. Sunlight exposure was the most common aggravating factor. Epidermal melasma was predominant in both groups (33.7% in Group A vs. 23.8% in Group B; p < 0.05). MASI scores showed a significant reduction in both groups: from 7.20 to 4.20 in Group A and from 5.40 to 4.10 in Group B by week 8 (p < 0.005 for both). Erythema was more frequent in Group A (18.7%) compared to Group B (2.5%, p < 0.05). However, post-inflammatory hyperpigmentation (PIH) was more common in Group B (10%) than in Group A (1.3%, p < 0.05). Conclusion: Topical 60% glycolic acid peel demonstrated greater therapeutic efficacy and a better safety profile than low-fluence Q-switched Nd: YAG laser in the treatment of melasma. PIH was notably more frequent in patients treated with laser, particularly those with darker skin types. Glycolic acid peel remains a favorable first-line treatment in such populations.

References

Syder NC, Elbuluk N. The history of melasma: Its roots and evolution. Dermatol Rev. 2023;4(1):5–11. https://doi.org/10.1002/der2.134

Christian G, Michelle R. An Update on New and Existing Treatments for the Management of Melasma. Am J Clin Dermatol 2024; 25:717–733 https://doi.org/10.1007/s40257-024-00863-2

Espósito AC, Cassiano DP, da Silva CN, Lima PB, Dias JAF, Hassun K, et al. Update on melasma-part I: pathogenesis. J Dermatol Ther (Heidelb). 2022;12(9):1967–88. https://doi.org/10.1007/s13555-022-00779-x

Chen Y, Vellaichamy G, Schneider S, Kong V, Zhichao L. Exposure factors in the occurrence and development of melasma (Review). J Exp Therap Med 2024; 27(4):1-7. https://doi.org/10.3892/etm.2024.12419

Lingjia Li, Xin Jiang, Yin Tu, Xin Zhang, Hua Gu, Li He.impact of blue light on skin pigmentation in patients with melasma. J Skin Res Tech 2023;29 (7): e13401. https://doi.org/10.1111/srt.1341

Gan C, Rodrigues M. An Update on New and Existing Treatments for the Management of Melasma. Am J Clin Dermatol 2024; 25:717 733 https://doi.org/10.1007/s40257-024-00863-2

Mukta S, Pearl EG, Valerie C, Corey LH, Susan CT, Nada E, et al. Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action. J Drugs Dermatol 2024;23(2):9-16. https://doi.org/10.36849/JDD.7428

Sahu P, Dayal S. Most worthwhile superficial chemical peel for melasma of skin of color: Authors’ experience of glycolic, trichloroacetic acid, and lactic peel. Dermatol Ther. 2021;34(1): e1469 https://doi.org/10.1111/dth.14693

Syder NC, Elbuluk N. The history of melasma: Its roots and evolution. Dermatol Rev. 2023;4(1):5–11. https://doi.org/10.1002/der2.134

Gao YL, Jia XX, Wang M, Hua Y, Zheng H, Xiang WZ, et al. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd: YAG laser treatment. Lasers Med Sci. 2019;34(4):767–71 https://doi.org/10.1007/s10103-018-2658-7

Syder Nicole, Nada E. The history of melasma: Its roots and evolution, Dermatol Rev 2022;1: 5-11. https://doi.org/10.1002/der2.134

Wolfgang G. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy. J Clin Cosm Inves Dermatol 2024; 17: 1203-16 https://doi.org/10.2147/CCID.S372456

Bosseila M, Ghonim N, Mostafa P. Efficacy and safety of different low fluences of Q-switched Nd: YAG laser in treatment of melasma: a split-face clinical and dermoscopic comparative study. Lasers Med Sci. 2022;37(1):675–80. https://doi.org/10.1007/s10103-020-03210-z

Pennitz A, Kinberger M, Avila Valle G, Passeron T, Nast A, Werner RN. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. Br J Dermatol. 2022;187(3):309–17. https://doi.org/10.1111/bjd.21244

Khan N, Hussain M, Muzaffar B, Siddique A, Khan R, Nazir T. Comparison Study Between Chemical Peeling with 70% Glycolic Acid and Intradermal Tranexamic Acid for the Treatment of Melasma PAFMJ 2024; 74 (2) 420-23 https://doi.org/10.51253/pafmj.v74i2.8565

Sachdeva S. Comparative Efficacy of 10 to 20% Trichloroacetic acid and 35-70% glycolic acid peel in 60 cases of melasma, Freckles, lentigines, and post-inflammatory hyperpigmentation. J Pakistan Asso Dermatol. 2006;16:74-78 https://jpad.com.pk/index.php/jpad/article/view/852/817

Fartasch M, Teal J, Menon G. Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier. Arch Dermatol Res 1997;289(7):404-9 https://doi.org/10.1007/s004030050212

Ertam SI, Marakli O, Oraloglu G, Bulut Okut E, Unal I. Comparison of 1064 nm Q-switched Nd: YAG laser and peeling in melasma treatment. Dermatol Ther. 2022;35(12): e15970 https://doi.org/10.1111/dth.15970

Sahu P, Dayal S. Most worthwhile superficial chemical peel for melasma of skin of color: Authors’ experience of glycolic, trichloroacetic acid, and lactic peel. Dermatol Ther. 2021;34(1): e1469 https://doi.org/10.1111/dth.14693

Kar HK, Gupta L, Chauhan A. A comparative study on the efficacy of high and low fluence Q-switched Nd: YAG lasers. J Cosmet Laser Ther. 2008;78:165-71. https://doi.org/10.4103/0378-6323.93633

Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B.et al. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol 2010;3(7):32-43 PMCID: PMC2921757

Puri N. A study on factional erbium glass laser therapy versus chemical peeling for the treatment of Melasma in female patients. J Cutan Aesthet Surg. 2013;6(3):148-51 https://doi.org/10.4103/0974-2077.118410.

Bansal C, Naik H, Kar HK, Chauhan A. A comparison of low fluence 1064 nm Q-switched Nd: Yag Laser with topical 20% azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg. 2012;5:266-72. https://doi.org/10.4103/0974-2077.104915